Loading clinical trials...

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy | Clinical Trials | Clareo Health

Back to search

COMPLETED

IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

NCT00620880•University of Zurich

View on ClinicalTrials.gov

Summary

Primary objective of the trial: To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Locations (1)

Zurich, Switzerland

Key Dates

Start Date

September 1, 2005

Completion Date

September 1, 2006

Last Updated

November 20, 2008

Conditions

Allergy to Cats

Interventions

Blood sample

BEHAVIORAL

Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge

NCT06069063

Allergy to Cats

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions